Articles
Consequences of the COVID-19 pandemic on cancer patients
In the COVID-19 era, oncologists all over the world have changed their schedules and daily routine practice according to recommendations from cancer professional associations, prioritising care of the most aggressive tumours and cancelling or postponing non-essential tests and screenings. Moreover,…
MDT meetings: why patient care suffers if I’m not there
In a disease as complex as cancer it seems the most logical way to ensure uniform standards of high quality care for all patients. Team meetings can also offer opportunities for education, provide a way to increase the number of…
Cancer and COVID-19 took the stage at AACR Annual Meeting
It was not scheduled in the original scientific program, but as the new coronavirus pandemic has started spreading all over the world, the American Association for Cancer Research (AACR) dedicated a plenary session of its Annual Meeting to this very…
Covid-19 pandemic: information and resources to support the cancer care community
As soon as the first analysis of the risk for severe COVID-19 in patients with cancer was published online in Lancet Oncology on February 14th, 2020, it emerged that these patients might have a higher risk of COVID-19 compared to…
Delivering the best cancer care during the pandemic
Key messages from the e-ESO faculty [caption id="attachment_9782" align="aligncenter" width="1440"] e-ESO coordinator Marco Siano, chief physician at the Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais Rennaz, Switzerland (left); ESO deputy scientific director Alex Eniu, medical oncologist and head of the breast…
The ABC Global Alliance launch a Global campaign to raise awareness about advanced breast cancer
There are over two million new cases of breast cancer a year in the world and 0.6 million deaths. About a third of all early breast cancer cases will become metastatic even with the best care, and the average overall…
Women make great surgeons, so why is the profession still dominated by men?
Professor Isabel Rubio is a surgeon at the top of her profession. She is Director of Breast Surgery at Clinica Universidad de Navarra, Madrid. She is President-elect of the European Society of Breast Cancer Specialists (EUSOMA) and head of public…
Evidence-based medicine and precision medicine – irreconcilable or inseparable?
"Medicine cannot be learned quickly, because it is impossible for there to exist any established method in it, as for example when someone who has learned to write in one way that is taught then understands everything. Medicine from one…
How retractions are helping cancer research
In 2015, cancer researcher Anil Potti - back then associated with Duke University in Durham, North Carolina - was found guilty of research misconduct by a US federal investigation led by the office for research integrity of the Department of…
Right drug, wrong patient: here’s how we improve our targeting
When it comes to precision and personalised medicine (PPM), clinical practice in oncology takes pride in developing and administering treatments that selectively target components of tumour cells. But, PPM is a model that also takes into account the inherent variability…